776.61MMarket Cap-7839P/E (TTM)
6.870High6.500Low83.23KVolume6.540Open6.450Pre Close558.10KTurnover0.10%Turnover RatioLossP/E (Static)114.12MShares10.24052wk High1.53P/B598.24MFloat Cap1.61052wk Low--Dividend TTM87.91MShs Float106.340Historical High--Div YieldTTM5.74%Amplitude1.610Historical Low6.705Avg Price1Lot Size
Mesoblast Stock Forum
Mesoblast (MESO) has released an update.
Mesoblast Limited has reported significant progress in its discussions with the FDA, receiving guidance on licensure paths for its innovative therapies, remestemcel-L for pediatric graft versus host disease, and rexlemestrocel-L for end-stage heart failure. The company is poised to resubmit its Biologics License Application for remestemcel-L and seeks an accelerated approval for ...
No comment yet